J. Safra Sarasin Holding
NVO icon

J. Safra Sarasin Holding’s Novo Nordisk NVO Stock Holding History

J. Safra Sarasin Holding’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.45M Buy
+134,442
New +$5.78M 0.09% 150
2025
Q3 		– Sell
-8,500
Closed -$587K – 526
2025
Q2 		$587K Buy
+8,500
New +$578K 0.01% 349

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Folketrygdfondet
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

J. Safra Sarasin Holding's NVO Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in Novo Nordisk (NVO) in Q2 2026: 134,442 shares worth $6.45M. The stake represents 0.09% of the portfolio and ranks #150 among its holdings. This is a return to the name: J. Safra Sarasin Holding previously reported a position in NVO as recently as Q2 2025.

J. Safra Sarasin Holding first reported a position in NVO in Q2 2025 and has held it in 2 quarters since. 1,358 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • J. Safra Sarasin Holding held 134,442 shares of Novo Nordisk worth $6.45M as of Q2 2026.
  • Novo Nordisk was a new J. Safra Sarasin Holding position in Q2 2026.
  • Novo Nordisk made up 0.09% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #150 holding.
  • J. Safra Sarasin Holding first reported a position in Novo Nordisk in Q2 2025 and has held it in 2 quarters since.
  • 1,358 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.